Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Institutions
Pharmaceutical companies
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Loading…

Medicines
New Zealand
Lanreotide

PHARMAC

Lanreotide

Mytolac S29

Inj 60 mg per 0.5 ml, 0.5 ml syringeNew ZealandFunded

Ask Osler about it

On this page

In other countries
Sources and licences

In other countries

The same active substances on other registers, the same brand first.

MytolacCanada · 120 MG / SYR · Solution (Extended-Release) · Advanz Pharma Canada INC.Same brand
MytolacCanada · 90 MG / SYR · Solution (Extended-Release) · Advanz Pharma Canada INC.Same brand
MytolacCanada · 60 MG / SYR · Solution (Extended-Release) · Advanz Pharma Canada INC.Same brand
Mytolac 120 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Orifarm A/SSame brand
Mytolac 120 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Orifarm A/SSame brand
Mytolac 120 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Amdipharm LimitedSame brand

More with the same substance on this register

MytolacLanreotide · Inj 60 mg per 0.5 ml, 0.5 ml syringeNew Zealand
MytolacLanreotide · Inj 90 mg per 0.5 ml, 0.5 ml syringeNew Zealand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

🇪🇸Myrelez 120 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 133,33 mg · solución inyectable en jeringa precargada · Amdipharm LimitedSame form

🇪🇸Myrelez 60 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 66,67 mg · solución inyectable en jeringa precargada · Amdipharm LimitedSame form

🇪🇸Myrelez 90 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 100 mg · solución inyectable en jeringa precargada · Amdipharm LimitedSame form

🇮🇹IpstylItaly · Soluzione iniettabile · Ipsen S.P.ASame form

🇮🇹LanrenetItaly · Soluzione iniettabile in siringa pre-riempita · Mylan S.P.A.Same form

🇮🇹Lanreotide SunItaly · Soluzione iniettabile in siringa pre-riempita · Sun Pharmaceutical Industries (Europe) B.V.Same form

🇷🇴SOMATULINE AUTOGEL 120 mgRomania · 120mg · sol. inj. in seringa preumpluta · Ipsen PharmaSame form

🇷🇴SOMATULINE PR 30 mgRomania · 30mg · pulb+solv. pt. susp. inj. cu elib.prel. · Ipsen PharmaSame form

🇷🇸Somatuline® Autogel®Serbia · 120mg · rastvor za injekciju u napunjenom injekcionom špricu · Pharmaswiss D.O.O., BeogradSame form

🇷🇸Somatuline® Autogel®Serbia · 90mg · rastvor za injekciju u napunjenom injekcionom špricu · Pharmaswiss D.O.O., BeogradSame form

🇷🇸Somatuline® Autogel®Serbia · 60mg · rastvor za injekciju u napunjenom injekcionom špricu · Pharmaswiss D.O.O., BeogradSame form

🇸🇦Somatuline Autogel 120 MG Solution for Injection in Pre-FilleSaudi Arabia · Ipsen Pharma BiotechSame form

🇸🇦Somatuline Autogel 60 MG Solution for Injection in Pre-FilleSaudi Arabia · Ipsen Pharma BiotechSame form

🇸🇦Somatuline Autogel 90 MG Solution for Injection in Pre-FilleSaudi Arabia · Ipsen Pharma BiotechSame form

🇸🇬Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 120 mgSingapore · 120 mg · injection, solution · Ipsen Pharma Singapore Pte. LTD.Same form

🇸🇬Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 60 mgSingapore · 60 mg · injection, solution · Ipsen Pharma Singapore Pte. LTD.Same form

🇸🇬Somatuline Autogel Prolonged Release Solution for Injection in a Pre-filled Syringe 90 mgSingapore · 90 mg · injection, solution · Ipsen Pharma Singapore Pte. LTD.Same form

🇧🇷Somatuline AutogelBrazil · Beaufour Ipsen Farmacêutica LtdaSame substance

🇧🇷Somatuline AutogelBrazil · Biosintética Farmacêutica LtdaSame substance

🇺🇸Lanreotide AcetateUnited States · 120MG BASE/0.5ML, 60MG BASE/0.2ML, 90MG BASE/0.3ML · solution · Invagen PharmsSame substance

🇺🇸Somatuline DepotUnited States · 120MG BASE/0.5ML, 60MG BASE/0.2ML, 90MG BASE/0.3ML · solution · Ipsen PharmaSame substance

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

PHARMAC, New Zealand

New Zealand Pharmaceutical Management Agency (PHARMAC); https://schedule.pharmac.govt.nz/pub/schedule/archive/Schedule_2026-10.xml; October 2026; published 2026-10-08; acquired 2026-10-13T22:49:29.739475+00:00. XML-to-graph and conservative medicine-domain projections are adaptations. Written attribution; PHARMAC logo excluded.

Licence: CC BY 4.0; PHARMAC Pharmaceutical Schedule XML files · Added 14 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Lanreotide
Dosage form: Inj 60 mg per 0.5 ml, 0.5 ml syringe
Register: New Zealand (PHARMAC)
Status: Funded
Status in the register: Funded by PHARMAC
Procedure: Community Pharmaceutical Schedule
Supply: Funded (PHARMAC)

PHARMAC

MytolacLanreotide · Inj 120 mg per 0.5 ml, 0.5 ml syringe🇳🇿New Zealand

PHARMACSomatuline AutogelLanreotide · Inj 60 mg per 0.5 ml, 0.5 ml syringe🇳🇿New Zealand

PHARMACSomatuline AutogelLanreotide · Inj 120 mg per 0.5 ml, 0.5 ml syringe🇳🇿New Zealand

PHARMACSomatuline AutogelLanreotide · Inj 90 mg per 0.5 ml, 0.5 ml syringe🇳🇿New Zealand